The development and registration of topical pharmaceuticals

International Journal of Pharmaceutics

Volumn 435, Issue 1, 2012, Pages 22-26

  Mugglestone, Christopher J ^a   Mariz, Segundo ^b   Lane, Majella E ^c  

^a CJ M Medical Limited   (United Kingdom)

^b School of Pharmacy ^*  (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Active Pharmaceutical Ingredient; Formulation; New Chemical Entity; Regulatory routes; Topical

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENT; STEROID; TOPICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG APPROVAL; DRUG FORMULATION; DRUG MARKETING; HUMAN; PHOTOSENSITIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTRATION; SKIN ATROPHY; STEROID THERAPY; TOPICAL TREATMENT; TOXICITY TESTING;

EID: 84864282940     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.03.052     Document Type: Article

References (24)

1. J.L. Aeling Topical treatment of allergic skin disorders D.Y.M. Leung, M.W. Greaves, Allergic Skin Disease: A Multidisciplinary Approach 2000 Marcel Dekker New York 502 532 p.
2. British National FormularyEDN 62nd ed. 2011 The Pharmaceutical Press
3. M. Brunner, P. Dehghanyar, B. Seigfried, W. Martin, G. Menke, and M. Müller Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation Br. J. Clin. Pharmacol. 60 2005 573 577 (Pubitemid 41532460)
4. M.J. Cork, J. Timmins, C. Holden, J. Carr, V. Berry, R. Tazi-Ahnini, and S.J. Ward An audit of adverse drug reactions to aqueous cream in children with atopic eczema Pharm. J. 271 2003 747 748 (Pubitemid 37536951)
5. N.H. Cox, and I.H. Coulson 8 ed. T. Burns, S. Breathnach, N. Cox, C. Griffiths, Chapter 5: Diagnosis of Skin Disease in Rook's Textbook of Dermatology vol. 1 2010 Wiley-Blackwellm 122
6. CPMP. The clinical requirements for locally applied, locally acting products containing known constuents CPMP/EWP/239/95 Note for Guidance on Local Acting and Locally Applied Agents.
7. C. Curdy, A. Naik, Y. Kalia, I. Alberti, and R.H. Guy Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo Int. J. Pharm. 271 2004 251 256 (Pubitemid 38210103)
8. B.L. Diffey, R.J. Oliver, and P.M. Farr A portable instrument for quantifying erythema induced by ultraviolet radiation Br. J. Dermatol. 111 1984 663 672 (Pubitemid 15222545)
9. Martindale Dimethyl sulfoxide S. Sweetman, The Complete Drug Reference 37th ed. 2011 The Pharmaceutical Press London
10. Directive, 2001/83/EC. Official Journal of the European Union. L311 67-128. 28/11/2001.
11. Directive, 2004/27/EC. Official Journal of the European Union. L136 34-57. 30/04/2004.
12. T.J. Franz Percutaneous absorption on the relevance of in vitro data J. Invest. Dermatol. 64 1975 190 195
13. J. Hadgraft, M. Whitefield, and P.H. Rosher Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study Skin Pharmacol Physiol 16 2003 137 142 (Pubitemid 36407888)
14. K.H. Kaidbey, and A.M. Kligman Identification of topical photosensitizing agents in humans J. Invest. Dermatol. 70 1978 149 151 (Pubitemid 8305609)
15. K.H. Kaidbey, and A.M. Kligman Photo maximization test for identifying photoallergic contact sensitizers Contact Dermatitis 6 1980 161 169 (Pubitemid 10102172)
16. J. Kanitakis Anatomy, histology and immunohistochemistry of normal human skin Eur. J. Dermatol. 12 2002 390 401 (Pubitemid 34713113)
17. L.K. Pershing, S. Bakhtian, C.E. Poncelet, J.L. Corlett, and V.P. Shah Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of Triamcinolone Acetonide cream strengths from two manufactured sources J. Pharm. Sci. 91 2002 1312 1323 (Pubitemid 34651193)
18. R.L. Phillips, and A.B. Sachs Skin biopsies for the measurement of clinical pharmacodynamic biomarkers Curr. Opin. Biotechnol. 16 2005 687 690 (Pubitemid 41654649)
19. H.L. Richards, D.G. Fortune, T.M. O'Sullivan, C.J. Main, and C.E.M. Griffiths Patients with psoriasis and their compliance with medication J. Am. Acad. Dermatol. 41 1999 581 583 (Pubitemid 29480408)
20. P. Santos, A.C. Watkinson, J. Hadgraft, and M.E. Lane Oxybutynin permeation in skin: the influence of drug and solvent activity Int. J. Pharm. 384 2010 67 72
21. H.A. Shelanski, and M.V. Shelanski A new technique of human patch tests Proc. Sci. Sec. Toilet Goods Assoc. 19 1957 46 49
22. E.W. Smith, E. Meyer, and J.M. Haigh The human skin blanching assay for topical corticosteroid bioavailability assessment V.P. Shah, H.I. Maibach, Topical Drug Bioavailability, Bioequivalence, and Penetration 1993 Plenum Press New York 155 162
23. R.N. Tettey-Amlalo, I. Kanfer, M.F. Skinner, E. Benfeldt, and R.K. Verbeeck Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel Eur. J. Pharm. Sci. 36 2009 219 225
24. R.M. Watkinson, R.H. Guy, G. Oliveira, J. Hadgraft, and M.E. Lane Optimisation of cosolvent concentration for topical drug delivery - III: influence of lipophilic vehicles on ibuprofen permeation Skin Pharmacol. Physiol. 24 2011 22 26